Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Always consult a qualified healthcare provider before beginning any peptide therapy
Two changes drive it: the One Big Beautiful Bill Acts temporary conversion factor increase and the CMS efficiency adjustment that partially offsets it
You only need to worry about this for the first 48 hours
Mitochondrial Impairment May Increase Cellular NAD(P)H: Resazurin Oxidoreductase [PMID: 26308058] Laboratory literature summary: Mitochondrial Impairment May Increase Cellular NAD(P)H: Resazurin Oxidoreductase Activity, Perturbing the NAD(P)H-Based Viability Assays
US$ 25.50
US$ 21.21
US$ 25.36
US$ 22.58
US$ 23.74
US$ 26.67
